Collegium Pharma (COLL) Misses Q3 EPS by 16c
Collegium Pharma (NASDAQ: COLL) reported Q3 EPS of ($0.46), $0.16 worse than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Collegium Pharma (COLL) click here.
Collegium Pharma (NASDAQ: COLL) reported Q3 EPS of ($0.46), $0.16 worse than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Collegium Pharma (COLL) click here.